Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.480 | 5.480 | 0.000 |
Shares | 94.690 | 94.690 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.352 | 23.153 |
Price to Book | 2.301 | 2.997 |
Price to Sales | 1.743 | 3.427 |
Price to Cash Flow | 11.247 | 14.779 |
Dividend Yield | 3.028 | 1.816 |
5 Years Earnings Growth | 20.157 | 19.923 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 97.730 | 97.143 |
Consumer Cyclical | 1.670 | 0.593 |
Basic Materials | 0.550 | 0.575 |
Industrials | 0.030 | 0.624 |
Technology | 0.030 | 0.618 |
Number of long holdings: 196
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nanjing King-friend Bio | CNE100002WP3 | 2.04 | 13.81 | +2.60% | |
Raas Blood A | CNE100000C31 | 1.78 | 7.38 | +0.82% | |
Livzon Pharm A | CNE0000002Y8 | 1.78 | 39.28 | -1.06% | |
Apeloa A | CNE000000Q45 | 1.65 | 15.55 | -1.77% | |
Hualan Biolog A | CNE000001JN8 | 1.58 | 19.65 | +0.26% | |
Kelun Pharm A | CNE100000PW7 | 1.57 | 33.64 | -0.21% | |
Shandong Pharm | CNE000001BG9 | 1.56 | 28.15 | +0.90% | |
China Medicine | CNE000001D56 | 1.56 | 35.49 | -1.03% | |
Huadong Med A | CNE0000011S1 | 1.52 | 33.25 | -0.15% | |
Hubei Jumpcan Pharm | CNE0000018X6 | 1.43 | 39.56 | -0.58% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TianHong SH Exchange 300 Index Fd A | 7.89B | 4.70 | -8.74 | - | ||
TianHong Vietnam Market Eq(QDII) A | 6.99B | 3.55 | 0.32 | - | ||
TianHong ChiNext Index A | 6.81B | -1.11 | -14.35 | - | ||
TianHong ChiNext Index C | 6.81B | -1.19 | -14.52 | - | ||
TianHong CSI Food Indus Index A | 5.36B | 0.83 | -11.75 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review